High affinity nucleic acid ligands to HIV integrase
First Claim
Patent Images
1. A purified and isolated non-naturally occurring nucleic acid ligand to HIV integrase.
3 Assignments
0 Petitions
Accused Products
Abstract
Methods are described for the identification and preparation of nucleic acid ligands to HIV integrase. Included in the invention are specific RNA ligands to HIV integrase identified by the SELEX method. Also included in the invention are specific RNA ligands that are inhibitors of HIV integrase.
-
Citations
16 Claims
- 1. A purified and isolated non-naturally occurring nucleic acid ligand to HIV integrase.
-
8. A nucleic acid ligand to HIV integrase identified according to the method comprising:
-
a) contacting a candidate mixture of nucleic acids with HIV integrase, wherein nucleic acids having an increased affinity to HIV integrase relative to the candidate mixture may be partitioned from the remainder of the candidate mixture; b) partitioning the increased affinity nucleic acids from the remainder of the candidate mixture; and c) amplifying the increased affinity nucleic acids to yield a mixture of nucleic acids enriched for nucleic acid sequences with relatively higher affinity and specificity for binding to HIV integrase, whereby a nucleic acid ligand of HIV integrase may be identified. - View Dependent Claims (9, 10, 11, 12, 13, 14, 15, 16)
-
Specification